Pembrolizumab vs Selenious Acid
Pembrolizumab vs Selenious Acid: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Selenious Acid.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days.
Chemical Properties
Type: Pembrolizumab β Antibody; Selenious Acid β Small molecule.